TIMP-4-prognostic marker and treatment target for triple-negative breast cancers

被引：0
|
作者：
Kunkel, Emily K. [1 ]
DuHadaway, James [1 ]
Sutanto-Ward, Erika [1 ]
Birnhak, Lauren N. [1 ]
Ringqvist, Jenny R. [1 ]
Ali, Zonera A. [2 ]
Gilman, Paul B. [2 ]
Prendergast, George C. [1 ]
Wallon, U. Margaretha [1 ]
机构：
[1] Lankenau Inst Med Res, Wynnewood, PA USA
[2] Lankenau Med Ctr, Wynnewood, PA USA
来源：
MOLECULAR CANCER RESEARCH | 2013年 / 11卷
关键词：
D O I：
10.1158/1557-3125.ADVBC-B070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B070
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers
    Vinet, Mathilde
    Suresh, Samyuktha
    Maire, Virginie
    Monchecourt, Clarisse
    Nemati, Fariba
    Lesage, Laetitia
    Pierre, Fabienne
    Ye, Mengliang
    Lescure, Auriane
    Brisson, Amelie
    Meseure, Didier
    Nicolas, Andre
    Rigaill, Guillem
    Marangoni, Elisabetta
    Del Nery, Elaine
    Roman-Roman, Sergio
    Dubois, Thierry
    CANCER MEDICINE, 2019, 8 (05): : 2414 - 2428
  • [42] Target Analysis and Mechanism of Podophyllotoxin in the Treatment of Triple-Negative Breast Cancer
    Zhang, Wenfeng
    Liu, Cun
    Li, Jie
    Liu, Ruijuan
    Zhuang, Jing
    Feng, Fubin
    Yao, Yan
    Sun, Changgang
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [43] MYC as a therapeutic target for the treatment of triple-negative breast cancer.
    Foley, Sarah A.
    Casten, Alina
    Kavanagh, Emma
    Synnott, Naoise C.
    Crown, John
    Larsson, Lars-Gunnar
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] New potential target for the treatment of triple-negative breast cancer identified
    不详
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (01) : 11 - 11
  • [45] circEPSTI1 as a prognostic marker and mediator of triple-negative breast cancer progression
    Chen, Bo
    Huang, Xiaojia
    Wei, Weidong
    Tang, Hailin
    Xie, Xiaoming
    CANCER RESEARCH, 2018, 78 (13)
  • [46] Bcl2 as a surrogate prognostic and predictive marker in triple-negative breast cancer
    Abdel-Fatah, T. M. A.
    Dickinson, P. D.
    Moseley, P.
    Reis-Filho, J. S.
    Green, A. R.
    Ellis, I. O.
    Chan, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] KDM5B is a prognostic marker of triple-negative breast cancer (TNBC)
    Almalki, N.
    Alsaleem, M.
    Rakha, E.
    Mongan, N.
    Allegrucci, C.
    JOURNAL OF PATHOLOGY, 2023, 261 : S37 - S37
  • [48] circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression
    Chen, Bo
    Wei, Weidong
    Huang, Xiaojia
    Xie, Xinhua
    Kong, Yanan
    Dai, Danian
    Yang, Lu
    Wang, Jin
    Tang, Hailin
    Xie, Xiaoming
    THERANOSTICS, 2018, 8 (14): : 4003 - 4015
  • [49] Androgen receptor expression as a prognostic and predictive marker in triple-negative breast cancer patients
    Zakaria, Fatma
    El-Mashad, Nehal
    Mohamed, Dareen
    ALEXANDRIA JOURNAL OF MEDICINE, 2016, 52 (02): : 131 - 140
  • [50] Triple-negative breast cancers - a panoply of cancer types
    Pareja, Fresia
    Reis-Filho, Jorge S.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (06) : 347 - 348
12345